2019
CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation
Esteghamat F, Broughton JS, Smith E, Cardone R, Tyagi T, Guerra M, SzabĂł A, Ugwu N, Mani MV, Azari B, Kayingo G, Chung S, Fathzadeh M, Weiss E, Bender J, Mane S, Lifton RP, Adeniran A, Nathanson MH, Gorelick FS, Hwa J, Sahin-TĂłth M, Belfort-DeAguiar R, Kibbey RG, Mani A. CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation. Nature Genetics 2019, 51: 1233-1243. PMID: 31358993, PMCID: PMC6675645, DOI: 10.1038/s41588-019-0470-3.Peer-Reviewed Original ResearchConceptsEarly-onset atherosclerosisMetabolic syndromeMetabolic syndrome traitsWhole-exome sequence analysisAttractive therapeutic targetPlatelet hyperactivationInsulin levelsPlasma insulinPlasma levelsInsulin sensitivityInsulin secretionTherapeutic targetPlatelet activationDisease mechanismsSyndrome traitsAtherosclerosisFunction mutationsSyndromeNovel lossInsulinMutationsSecretion
2001
In vivo cerulein hyperstimulation of rat pancreas is associated with redistribution of the cation-independent mannose 6-phoshate receptor
Karne S, Mani A, Kolodecik T, Gorelick F, Haven C. In vivo cerulein hyperstimulation of rat pancreas is associated with redistribution of the cation-independent mannose 6-phoshate receptor. Gastroenterology 2001, 120: a719. DOI: 10.1016/s0016-5085(08)83579-2.Peer-Reviewed Original ResearchIn vivo cerulein hyperstimulation of rat pancreas is associated with redistribution of the cation-independent mannose 6-phoshate receptor
KARNE S, MANI A, KOLODECIK T, GORELICK F, CT H. In vivo cerulein hyperstimulation of rat pancreas is associated with redistribution of the cation-independent mannose 6-phoshate receptor. Gastroenterology 2001, 120: a719-a719. DOI: 10.1016/s0016-5085(01)83579-4.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply